Endurance Wealth Management’s Immunic IMUX Stock Holding History

Endurance Wealth Management’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$1K	Hold	50	–	–	﹤0.01%	623
2023 Q1	$0	Hold	50	–	–	﹤0.01%	650
2022 Q4	$1K	Hold	50	–	–	﹤0.01%	614
2022 Q3	$2K	Hold	50	–	–	﹤0.01%	565
2022 Q2	$2K	Hold	50	–	–	﹤0.01%	581
2022 Q1	$6K	Hold	50	–	–	﹤0.01%	548
2021 Q4	$5K	Hold	50	–	–	﹤0.01%	544
2021 Q3	$8K	Hold	50	–	–	﹤0.01%	544
2021 Q2	$4K	Hold	50	–	–	﹤0.01%	566
2021 Q1	$8K	Hold	50	–	–	﹤0.01%	545
2020 Q4	$7K	Hold	50	–	–	﹤0.01%	521
2020 Q3	$12K	Sell	50 -50	-50%	-$8.19K	﹤0.01%	447
2020 Q2	$12K	Buy	+100	New	+$10.2K	﹤0.01%	451

Other funds holding IMUX

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

Endurance Wealth Management's IMUX Position: Q2 2023 in Review

Endurance Wealth Management held its Immunic (IMUX) position steady in Q2 2023 at 50 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #623.

Endurance Wealth Management first reported a position in IMUX in Q2 2020 and has held it in 13 quarters since. The position peaked at $12K in Q3 2020. 63 funds tracked by Wall St. Rank hold IMUX as of Q2 2023.

Endurance Wealth Management held 50 shares of Immunic worth $1K as of Q2 2023.
Endurance Wealth Management left its Immunic share count unchanged in Q2 2023.
Immunic made up ﹤0.01% of Endurance Wealth Management's portfolio in Q2 2023, its #623 holding.
Endurance Wealth Management first reported a position in Immunic in Q2 2020 and has held it in 13 quarters since.
Endurance Wealth Management's Immunic position peaked at $12K in Q3 2020.
63 funds tracked by Wall St. Rank held Immunic as of Q2 2023.

Based on Endurance Wealth Management's 13F filing for Q2 2023, filed 9 Aug 2023.